Mesa Laboratories Stock Buy Hold or Sell Recommendation
| MLAB Stock | USD 104.47 2.15 2.02% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Mesa Laboratories is 'Cautious Hold'. Macroaxis provides Mesa Laboratories buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MLAB positions. The advice algorithm takes into account all of Mesa Laboratories' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Mesa Laboratories' buy or sell advice are summarized below:
Real Value 87.74 | Target Price 139 | Hype Value 106.62 | Market Value 104.47 | Naive Value 101.71 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Mesa Laboratories given historical horizon and risk tolerance towards Mesa Laboratories. When Macroaxis issues a 'buy' or 'sell' recommendation for Mesa Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
Mesa |
Execute Mesa Laboratories Buy or Sell Advice
The Mesa recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mesa Laboratories. Macroaxis does not own or have any residual interests in Mesa Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mesa Laboratories' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Mesa Laboratories Trading Alerts and Improvement Suggestions
| Mesa Laboratories had very high historical volatility over the last 90 days | |
| Over 92.0% of the company shares are owned by institutional investors | |
| On 15th of March 2024 Mesa Laboratories paid $ 0.16 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Investors in Mesa Laboratories have made a strong return of 153 percent over the past five years - Yahoo Movies UK |
Mesa Laboratories Returns Distribution Density
The distribution of Mesa Laboratories' historical returns is an attempt to chart the uncertainty of Mesa Laboratories' future price movements. The chart of the probability distribution of Mesa Laboratories daily returns describes the distribution of returns around its average expected value. We use Mesa Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mesa Laboratories returns is essential to provide solid investment advice for Mesa Laboratories.
| Mean Return | 0.29 | Value At Risk | -4.69 | Potential Upside | 5.64 | Standard Deviation | 3.11 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mesa Laboratories historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Mesa Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Mesa Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mesa Laboratories backward and forwards among themselves. Mesa Laboratories' institutional investor refers to the entity that pools money to purchase Mesa Laboratories' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2023-12-31 | 111.1 K | Kennedy Capital Management Inc | 2023-12-31 | 107.1 K | Glenmede Trust Co Na | 2023-12-31 | 90.9 K | Northern Trust Corp | 2023-12-31 | 81.5 K | Granahan Investment Management Inc.. | 2023-12-31 | 71.9 K | Bank Of New York Mellon Corp | 2023-12-31 | 61.1 K | Ameriprise Financial Inc | 2023-12-31 | 54.6 K | Raymond James & Associates | 2023-12-31 | 47 K | Comerica Bank | 2023-12-31 | 45.5 K | Blackrock Inc | 2023-12-31 | 845.9 K | Conestoga Capital Advisors, Llc | 2023-12-31 | 578.5 K |
Mesa Laboratories Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 414K | 929K | (1.0M) | (10.2M) | (9.2M) | (8.7M) | |
| Change In Cash | 71.2M | 182.5M | (214.5M) | (16.4M) | (18.9M) | (18.0M) | |
| Free Cash Flow | 25.1M | 35.1M | 34.8M | 23.4M | 27.0M | 28.3M | |
| Depreciation | 13.0M | 17.7M | 25.1M | 33.8M | 38.9M | 40.8M | |
| Other Non Cash Items | 11.8M | 5.1M | 8.0M | 1.3M | 1.5M | 1.6M | |
| Capital Expenditures | 1.5M | 2.0M | 4.4M | 4.5M | 5.2M | 5.5M | |
| Net Income | 1.3M | 3.3M | 1.9M | 930K | 1.1M | 1.0M | |
| End Period Cash Flow | 81.4M | 263.9M | 49.3M | 32.9M | 37.8M | 39.7M | |
| Dividends Paid | 2.7M | 3.2M | 3.3M | 3.4M | 3.9M | 2.2M | |
| Change Receivables | 1.6M | (1.7M) | (647K) | (2.1M) | (1.9M) | (1.8M) | |
| Net Borrowings | 144.1M | (664K) | 49M | (36M) | (41.4M) | (39.3M) | |
| Change To Netincome | 6.9M | 11.3M | 19.5M | 10.3M | 11.9M | 12.5M | |
| Investments | (185.6M) | (2.0M) | (305.2M) | (9.5M) | (8.5M) | (9.0M) |
Mesa Laboratories Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Mesa Laboratories or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Mesa Laboratories' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Mesa stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.08 | |
β | Beta against NYSE Composite | 2.36 | |
σ | Overall volatility | 3.06 | |
Ir | Information ratio | 0.06 |
Mesa Laboratories Volatility Alert
Mesa Laboratories shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Mesa Laboratories' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Mesa Laboratories' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Mesa Laboratories Fundamentals Vs Peers
Comparing Mesa Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mesa Laboratories' direct or indirect competition across all of the common fundamentals between Mesa Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mesa Laboratories or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mesa Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing Mesa Laboratories by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Mesa Laboratories to competition |
| Fundamentals | Mesa Laboratories | Peer Average |
| Return On Equity | 0.0024 | -0.31 |
| Return On Asset | 0.0013 | -0.14 |
| Profit Margin | 0 % | (1.27) % |
| Operating Margin | 0.02 % | (5.51) % |
| Current Valuation | 788.31 M | 16.62 B |
| Shares Outstanding | 5.39 M | 571.82 M |
| Shares Owned By Insiders | 5.73 % | 10.09 % |
| Shares Owned By Institutions | 92.31 % | 39.21 % |
| Number Of Shares Shorted | 191.02 K | 4.71 M |
| Price To Earning | 433.94 X | 28.72 X |
| Price To Book | 1.41 X | 9.51 X |
| Price To Sales | 2.66 X | 11.42 X |
| Revenue | 219.08 M | 9.43 B |
| Gross Profit | 116.55 M | 27.38 B |
| EBITDA | 3.32 M | 3.9 B |
| Net Income | 930 K | 570.98 M |
| Cash And Equivalents | 43.75 M | 2.7 B |
| Cash Per Share | 8.23 X | 5.01 X |
| Total Debt | 170.27 M | 5.32 B |
| Debt To Equity | 0.57 % | 48.70 % |
| Current Ratio | 2.90 X | 2.16 X |
| Book Value Per Share | 74.70 X | 1.93 K |
| Cash Flow From Operations | 27.98 M | 971.22 M |
| Short Ratio | 5.05 X | 4.00 X |
| Earnings Per Share | 0.17 X | 3.12 X |
| Target Price | 130.0 | |
| Number Of Employees | 698 | 18.84 K |
| Beta | 0.83 | -0.15 |
| Market Capitalization | 575.11 M | 19.03 B |
| Total Asset | 661.83 M | 29.47 B |
| Retained Earnings | 74.2 M | 9.33 B |
| Working Capital | 75.62 M | 1.48 B |
| Current Asset | 10.74 M | 9.34 B |
Note: Disposition of 420 shares by Brian Archbold of Mesa Laboratories at 142.4 subject to Rule 16b-3 [view details]
Mesa Laboratories Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mesa . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 992.46 | |||
| Daily Balance Of Power | (0.39) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 106.02 | |||
| Day Typical Price | 105.5 | |||
| Market Facilitation Index | 3.0E-4 | |||
| Price Action Indicator | (2.63) | |||
| Period Momentum Indicator | (2.15) |
About Mesa Laboratories Buy or Sell Advice
When is the right time to buy or sell Mesa Laboratories? Buying financial instruments such as Mesa Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 22.8M | 20.0M | 22.9M | 24.1M | Total Assets | 707.4M | 661.8M | 761.1M | 799.2M |
Use Investing Ideas to Build Portfolios
In addition to having Mesa Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency Thematic Idea Now
Cryptocurrency
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Mesa Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.Note that the Mesa Laboratories information on this page should be used as a complementary analysis to other Mesa Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Mesa Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share 0.17 | Revenue Per Share 39.604 | Quarterly Revenue Growth (0.01) |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.